FDA Approves YORVIPATH (Palopegteriparatide) as the First and Only Treatment for Hypoparathyroidism in Adults Read more
GSK’s Jemperli (dostarlimab) plus chemotherapy approved in Singapore as the first frontline immuno-oncology treatment for dMMR/MSI-H primary advanced or recurrent endometrial cancer Read more
Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070 Read more
Servier’s VORANIGO (vorasidenib) Tablets Receives FDA Approval as First Targeted Therapy for Grade 2 IDH-mutant Glioma Read more
Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases Read more
SK pharmteco and Rznomics Explore Collaboration for RNA-based Gene Therapy Development and Manufacturing Read more
Roche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary care Read more